CMBA
XYL icon

C.M. Bidwell & Associates’s Xylem XYL Stock Holding History

C.M. Bidwell & Associates’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30
Closed -$4.05K – 539
2024
Q3 		$4.05K Buy
+30
New +$4.01K ﹤0.01% 371
2021
Q4 		– Sell
-7
Closed -$1K – 648
2021
Q3 		$1K Hold
7
– – ﹤0.01% 556
2021
Q2 		$1K Buy
+7
New +$799 ﹤0.01% 558
2018
Q2 		– Sell
-6,120
Closed -$471K – 460
2018
Q1 		$471K Buy
6,120
+210
+4% +$15.5K 0.43% 61
2017
Q4 		$403K Sell
5,910
-110
-2% -$7.3K 0.35% 85
2017
Q3 		$377K Buy
+6,020
New +$360K 0.58% 60
2016
Q3 		– Sell
-92,830
Closed -$4.14M – 331
2016
Q2 		$4.14M Hold
92,830
– – 1.03% 29
2016
Q1 		$3.8M Buy
+92,830
New +$3.42M 0.95% 42

Other funds holding XYL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

C.M. Bidwell & Associates's XYL Position: Q4 2024 in Review

C.M. Bidwell & Associates sold out of Xylem (XYL) in Q4 2024, closing a stake of 30 shares — an estimated $4.05K sold.

C.M. Bidwell & Associates first reported a position in XYL in Q1 2016 and held it in 8 quarters. The position peaked at $4.14M in Q2 2016. 1,001 funds tracked by Wall St. Rank hold XYL as of Q4 2024.

  • C.M. Bidwell & Associates reported no remaining Xylem position as of Q4 2024 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 30 Xylem shares in Q4 2024, an estimated $4.05K.
  • C.M. Bidwell & Associates first reported a position in Xylem in Q1 2016 and held it in 8 quarters.
  • C.M. Bidwell & Associates's Xylem position peaked at $4.14M in Q2 2016.
  • 1,001 funds tracked by Wall St. Rank held Xylem as of Q4 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.